Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons

Endocrinology

Volumn 145, Issue 7, 2004, Pages 3065-3073

  Nathan, Britto P ^a   Barsukova, Anna G ^a   Shen, Fei ^a   McAsey, Mary ^b   Struble, Robert G ^b  

^a EASTERN ILLINOIS UNIVERSITY   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ESTROGEN;

ANIMAL CELL; ANIMAL CELL CULTURE; BRAIN CELL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; ESTROGEN THERAPY; FEMALE; GENOTYPE; MEDICAL LITERATURE; MOUSE; NERVE FIBER GROWTH; NEURITE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; RISK FACTOR;

AGE FACTORS; ANIMALS; APOLIPOPROTEINS E; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; ISOMERISM; LIPIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURITES; NEURONS;

EID: 3042647308     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1707     Document Type: Review

References (54)

1. Paganini-Hill A, Henderson V 1994 Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140:256-261
2. Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB 1994 Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 140:262-267
3. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R 1996 Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432
4. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E 1997 A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521
5. LeBlanc ES, Janowsky J, Chan BK, Nelson HD 2001 Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285:1489-1499
6. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC 2002 Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288:2123-2129
7. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D, WHIMS Investigators 2003 Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2663-2672
8. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones 3rd BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J, WHIMS Investigators 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662
9. Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B 1995 The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in Northern Manhattan, 1988-1993. Am J Epidemiol 142:820-827
10. Kuopio AM, Marttila RJ, Helenius H, Rinne UK 1999 Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology 52:302-308
11. Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S 1999 The effect of estrogen replacement on early Parkinson's disease. Neurology 52:1417-1421
12. Marder K, Tang MX, Alfaro B, Mejia H, Cote L, Jacobs D, Stern Y, Sano M, Mayeux R 1998 Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 50:1141-1143
13. Smith R, Studd JW 1992 A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med 85:612-613
14. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR 2002 Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52:421-428
15. Mahley RW 1988 Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630
16. Weisgraber KH 1994 Apolipoprotein E: structure-function relationships. Adv Protein Chem 45:249-302
17. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
18. Roses AD 1997 Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol Dis 4:170-185
19. Strittmatter WJ, Roses AD 1996 Apolipoprotein E and Alzheimer's. Annu Rev Neurosci 19:53-77
20. Tang G, Xie H, Xu L, Hao Y, Lin D, Ren D 2002 Genetic study of apolipoprotein E gene, α-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet 114:446-449
21. Zareparsi S, Camicioli R, Sexton G, Bird T, Swanson P, Kaye J, Nutt J, Payami H 2002 Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet 107:156-161
22. Mayeux R, Ottman R, Maestre G, Ngai C, Tang MX, Ginsberg H, Chun M, Tycko B, Shelanski M 1995 Synergistic effects of traumatic head injury and apolipoprotein-ε4 in patients with Alzheimer's disease. Neurology 45:555-557
23. Teasdale GM, Nicoll JA, Murray G, Fiddes M 1997 Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350:1069-1071
24. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S 1997 Apolipoprotein E ε4 associated with chronic traumatic brain injury. JAMA 278:136-140
25. Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, Enzinger C, Schiefermeier M, Schwarz C, Kornek B, Reindl M, Huber K, Grass R, Wimmer G, Vass K, Pfeiffer KH, Hartung HP, Schmidt R 2001 Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 57:853-857
26. Masterman T, Zhang Z, Hellgren D, Salter H, Anvret M, Lilius L, Lannfelt L, Hillert J 2002 APOE genotypes and disease severity in multiple sclerosis. Mult Scler 8:98-103
27. Ferreira A, Caceres A 1991 Estrogen-enhanced neurite growth: evidence for a selective induction of τ and stable microtubules. J Neurosci 11:392-401
28. Diaz H, Lorenzo A, Carrer HF, Caceres A 1992 Time lapse study of neurite growth in hypothalamic dissociated neurons in culture: sex differences and estrogen. J Neurosci Res 33:266-281
29. Brinton RD, Tran J, Proffitt P, Montoya M 1997 17beta]-Estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem Res 22:1339-1351
30. Morse JK, DeKosky ST, Scheff SW 1992 Neurotrophic effects of steroids on lesion-induced growth in thehippocampus. II. Hormone replacement. Exp Neurol 118:47-52
31. Stone DJ, Rozovsky I, MorganTE, Anderson CP, Finch CE 1998 Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J Neurosci 18:3180-3185
32. Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, Mahley RW, Pitas RE 1995 The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 270:19791-19799
33. Nathan BP, Jiang Y, Wong GK, Shen F, Brewer GJ, Struble RG 2002 Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res 928:96-105
34. Sun Y, Wu S, Bu G, Onifade MK, Patel SN, LaDu MJ, Fagan AM, Holtzman DM 1998 Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci 18:3261-3272
35. Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, Zedlick D, Marcova L 1997 Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele. J Neurosci 17:516-529
36. Struble RG, Rosario ER, Kircher ML, Ludwig SM, McAdamis PJ, Watabe K, McAsey ME, Cady C, Nathan BP 2003 Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17β estradiol. Exp Neurol 183:638-644
37. Levin-Allerhand J, McEwen BS, Lominska CE, Lubahn, DB, Korach, KS, Smith, JD 2001 Brain region-specific up-regulation of mouse apoliporotein E by pharmacological estrogen treatments. J Neurochem 79:796-803
38. Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE 1997 Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol 143:313-318
39. Rozovsky I, Hoving S, Anderson CP, O'Callaghan J, Finch CE 2002 Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixed cultures. Neurosci Lett 323:191-194
40. Brewer GJ 1997 Isolation and culture of adult rat hippocampal neurons. J Neurosci Methods 71:143-155
41. Demeester N, Castro G, Desrumaux C, De Geitere C, Fruchart JC, Santens P, Mulleners E, Engelborghs S, De Deyn PP, Vandekerckhove J, Rosseneu M, Labeur C 2000 Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. J Lipid Res 41:963-974
42. Walmer DK, Wrona MA, Hughes CL, Nelson KG 1992 Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinology 131:1458-1466
43. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM 2002 Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J Neurosci Res 68:331-336
44. Brinton RD 2001 Cellular and molecular mechanisms of estrogen regulation of memory function neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn Mem 8:121-133
45. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM 1985 Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501-1513
46. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW 1987 Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917:48-61
47. Nathan BP, Nisar R, Randall S, Short J, Sherrow M, Wong GK, Struble, RG 2001 Time course of apolipoprotein E levels following olfactory nerve lesioning in mice. Exp Neurol 172:128-136
48. Slezak M, Pfrieger FW 2003 New roles for astrocytes: Regulation of CNS synaptogenesis. Trends Neurosci 26:531-535
49. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL 1995 Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA 92:9480-9484
50. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE 1995 Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 270:27063-27071
51. Saunders AM 2000 Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses. J Neuropathol Exp Neurol 59:751-758
52. Qiu Z, Crutcher KA, Hyman BT, Rebeck GW 2003 ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 122:291-303
53. Buttini M, Akeefe H, Lin C, Mahley RW, Pitas RE, Wyss-Coray T, Mucke L 2000 Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 97:207-210
54. Yaffe K, Haan M, Byers A, Tangen C, Kuller L 2000 Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54:1949-1954